WCG Clinical, Inc. (WCGC)
WCG Clinical has a market cap or net worth of $6.05 billion. The enterprise value is $7.28 billion.
WCG Clinical has 378.26 million shares outstanding.
|Shares Change (YoY)||n/a|
|Shares Change (QoQ)||n/a|
|Owned by Insiders (%)||n/a|
|Owned by Institutions (%)||n/a|
The stock's EV/EBITDA ratio is 37.66, with a EV/FCF ratio of 67.55.
|EV / Earnings||n/a|
|EV / Sales||14.64|
|EV / EBITDA||37.66|
|EV / EBIT||n/a|
|EV / FCF||67.55|
The company has a current ratio of n/a, with a Debt / Equity ratio of 0.73.
|Debt / Equity||0.73|
|Debt / EBITDA||7.27|
|Debt / FCF||13.03|
|Return on Equity (ROE)||n/a|
|Return on Assets (ROA)||n/a|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||$376,387|
|Profits Per Employee||-$64,906|
|Effective Tax Rate||n/a|
Stock Price Statistics
|Total Price Change||n/a|
|50-Day Moving Average||n/a|
|200-Day Moving Average||n/a|
|Average Volume (30 Days)||n/a|
Short Selling Information
|Short % of Shares Out||n/a|
|Short % of Float||n/a|
|Short Ratio (days to cover)||n/a|
In the last 12 months, WCG Clinical had revenue of $497.58 million and -85.81 million in losses. Earnings per share was -$0.23.
|Earnings Per Share (EPS)||-$0.23|
The company has $174.99 million in cash and $1.41 billion in debt, giving a net cash position of -$1.23 billion or -$3.25 per share.
|Cash & Cash Equivalents||174.99M|
|Net Cash Per Share||-$3.25|
|Book Value Per Share||5.07|
In the last 12 months, operating cash flow was $139.87 million and capital expenditures -$32.06 million, giving a free cash flow of $107.80 million.
|Operating Cash Flow||139.87M|
|Free Cash Flow||107.80M|
|FCF Per Share||$0.28|
Gross margin is 63.14%, with operating and profit margins of -4.24% and -17.24%.
Dividends & Yields
WCG Clinical does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|